Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for NanoString Technologies, Inc. (NSTG : NSDQ)

• Company Description    NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington. Number of Employees: 766

• Price / Volume Information    Yesterday's Closing Price: $16.01 Daily Weekly Monthly 20 Day Moving Average: 1,055,550 shares Shares Outstanding: 46.42 (millions) Market Capitalization: $743.12 (millions) Beta: 1.98 52 Week High: $70.40 52 Week Low: $13.52 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -18.94% -8.71% 12 Week -53.13% -48.48% Year To Date -62.09% -53.88%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 530 FAIRVIEW AVENUE NORTH SUITE 2000 - SEATTLE,WA 98109 USA ph: 206-378-6266 fax: 206-378-6288 investorrelations@nanostring.com http://www.nanostring.com

• General Corporate Information    Officers R. Bradley Gray - President; Chief Executive Officer William D. Young - Chairman of the Board of Directors K. Thomas Bailey - Chief Financial Officer Elisha W. Finney - Director Janet George - Director Peer Information NanoString Technologies, Inc. (BJCT) NanoString Technologies, Inc. (CADMQ) NanoString Technologies, Inc. (APNO) NanoString Technologies, Inc. (UPDC) NanoString Technologies, Inc. (IMTIQ) NanoString Technologies, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 63009R109 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 46.42 Most Recent Split Date: (:1) Beta: 1.98 Market Capitalization: $743.12 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.67 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.64 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.11 Price/Cash Flow: - Price / Sales: 5.14 EPS Growth vs. Year Ago Period: -38.71% vs. Previous Quarter: -34.38% Sales Growth vs. Year Ago Period: -1.70% vs. Previous Quarter: -26.79% ROE 03/31/22 - -68.57 12/31/21 - -55.40 09/30/21 - -45.31 ROA 03/31/22 - -26.32 12/31/21 - -22.98 09/30/21 - -21.05 Current Ratio 03/31/22 - 7.81 12/31/21 - 8.20 09/30/21 - 10.03 Quick Ratio 03/31/22 - 7.11 12/31/21 - 7.60 09/30/21 - 9.33 Operating Margin 03/31/22 - -87.89 12/31/21 - -79.44 09/30/21 - -78.48 Net Margin 03/31/22 - -87.89 12/31/21 - -79.44 09/30/21 - -78.48 Pre-Tax Margin 03/31/22 - -87.76 12/31/21 - -79.32 09/30/21 - -78.38 Book Value 03/31/22 - 3.13 12/31/21 - 3.88 09/30/21 - 4.37 Inventory Turnover 03/31/22 - 2.14 12/31/21 - 2.36 09/30/21 - 2.42 Debt-to-Equity 03/31/22 - 1.55 12/31/21 - 1.27 09/30/21 - 1.13 Debt-to-Capital 03/31/22 - 60.81 12/31/21 - 55.99 09/30/21 - 53.03

Powered by Zacks Investment Research ©